Clinical effect of prostaglandins combined with oxytocin in the prevention of high risk pregnancy and postpartum hemorrhage after cesarean section
-
Received Date:
2018-02-03
Accepted Date:
2019-01-30
-
Abstract
ObjectiveTo investigate the preventive effects of carboprost tromethamine or carboprost methylate combined with oxytocin on postpartum hemorrhage in high risk pregnant women treated with cesarean section.MethodsOne hundred and eighty high risk pregnant women treated with cesarean section were randomly divided into group A and group B(90 cases each group).Group A was intravenously injected with 10 U oxytocin combined with intramuscular injection 250 μg carboprost tromethamine, and group B was intravenously injected with 10 U oxytocin combined with 1 mg carboprost methylate by sublingual administration after delivery.The amount of bleeding, and rates of postpartum hemorrhage, blood transfusion, intervention of additional hemostasis and occurrence of adverse reaction were compared between two groups.ResultsThe intraoperative, postoperative 2 h and postoperative 24 h haemorrhage amount in group A were significantly less than those in group B(P < 0.05 to P < 0.01).The differences of the incidence of postpartum hemorrhage, and rates of blood transfusion and intervention of additional hemostatic measures between two groups were not statistically significnat(P>0.05).The average amount of postpartum bleeding in 12 cases of group A and 17 cases of group B were[(841.34±232.56)mL] and[(857.62±227.37)mL], respectively, and the difference of which was not statistically significant(P>0.05).The difference of the incidence rate of adverse reaction between two gorups was not statistically significant(P>0.05).ConclusionsCarboprost tromethamine or carboprost methylate combined with oxytocin in treating postpartum hemorrhage in high-risk pregnant treated with cesarean section has good preventive effect and less side effects.Carboprost tromethamine has a certain advantage in reducing the amount of bleeding.
-
-
References
[1]
|
庞土寿.缩宫素联合前列腺素类药物预防高危妊娠且行剖宫产产后出血的临床观察[J].临床医学工程, 2016, 23(11):1497. doi: 10.3969/j.issn.1674-4659.2016.11.1497 |
[2]
|
刘亚新.卡前列甲酯栓联合催产素预防高危妊娠剖宫产宫缩乏力性出血临床观察[J].中国处方药, 2017, 15(07):89. doi: 10.3969/j.issn.1671-945X.2017.07.061 |
[3]
|
刘伟靓, 姚丽, 曹士红, 等.产褥期感染相关危险因素的评估[J].郑州大学学报(医学版), 2017, 52(2):205. |
[4]
|
戴中超.卡前列素氨丁三醇预防高危妊娠产妇产后出血的临床疗效[J].临床合理用药杂志, 2016, 9(6):15. |
[5]
|
王瑞姣, 韩汝芳, 颜杰文, 等.缩宫素联合卡前列素氨丁三醇预防高危产妇剖宫产产后出血的效果研究[J].中国妇幼保健, 2016, 31(15):3033. |
[6]
|
连海丽.卡前列素氨丁三醇联合缩宫素在高危妊娠剖宫产术后产后出血的防治效果[J].中国实用医药, 2016, 11(29):175. |
[7]
|
谢幸, 苟文丽.妇产科学[M].8版.北京:人民卫生出版社, 2013. |
[8]
|
潘琴.卡前列素氨丁三醇联合缩宫素在高危妊娠且行剖宫产术中的应用价值分析[J].解放军医药杂志, 2017, 29(9):6. doi: 10.3969/j.issn.2095-140X.2017.09.002 |
[9]
|
李丽, 袁秀红, 罗晓梅, 等.缩宫素联合前列腺素类药物预防高危妊娠且行剖宫产产后出血的临床观察[J].现代药物与临床, 2014, 29(6):619. |
[10]
|
刘晓霞.卡前列甲酯栓联合卡前列素氨丁三醇治疗宫缩乏力性产后出血的临床研究[J].中国基层医药, 2017, 24(2):231. doi: 10.3760/cma.j.issn.1008-6706.2017.02.019 |
[11]
|
涂红星.高危妊娠行剖宫产产后出血的预防[J].中国妇幼保健, 2013, 28(21):3428. doi: 10.7620/zgfybj.j.issn.1001-4411.2013.21.15 |
[12]
|
王琼林, 王梅, 王睿.卡前列素氨丁三醇预防性用于产后出血高危因素产妇疗效观察[J].现代中西医结合杂志, 2013, 22(23):2538. doi: 10.3969/j.issn.1008-8849.2013.23.011 |
[13]
|
赵荷兰.米索前列醇联合缩宫素在防止高危产妇剖宫产术中术后出血的效果研究[J].实用预防医学, 2015, 22(1):82. doi: 10.3969/j.issn.1006-3110.2015.01.025 |
[14]
|
王少梅.卡前列素氨丁三醇预防高危妊娠剖宫产产后出血的临床疗效及安全性探讨[J].中国当代医药, 2014, 21(7):81. |
[15]
|
牛丽娜, 李晓琴, 马萍.卡前列素氨丁三醇注射液联合低位B-Lynch缝合术治疗难治性前置胎盘产后出血的临床疗效及安全性评价[J].中国基层医药, 2016, 23(20):3087. doi: 10.3760/cma.j.issn.1008-6706.2016.20.013 |
[16]
|
冯可几, 王馨芸.高危妊娠剖宫产孕妇应用益母草联合卡前列甲酯栓的效果观察[J].临床合理用药杂志, 2012, 5(21):60. doi: 10.3969/j.issn.1674-3296.2012.21.046 |
-
-
Proportional views
-